Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 1
1(33.3%)
Phase 3
1(33.3%)
3Total
N/A(1)
Phase 1(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03903835Phase 3Recruiting

ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer

Role: collaborator

NCT05865782Not ApplicableRecruiting

Reconstructing Schoolyards With Greenery to Increase Schoolchildren's Physical Activity and Mitigate Climate Changes

Role: collaborator

NCT01959438Phase 1Unknown

Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma

Role: collaborator

All 3 trials loaded